Editas Medicine Inc (EDIT) — Cash Flow Reinvestment Rate
Latest as of December 2019:
0.27x
Editas Medicine Inc (EDIT) has a Cash Flow Reinvestment Rate of 0.27x as of December 2019, reinvesting $11.13 Million (capex $1.69 Million plus investments $9.44 Million) from operating cash flow of $41.02 Million. See free cash flow generation of Editas Medicine Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.27x
(Capex + Investments) / Operating CF
Total Reinvested
$11.13 Million
Capex + Investments
Operating Cash Flow
$41.02 Million
USD
Capital Expenditures
$1.69 Million
USD
Annual Cash Flow Reinvestment Rate for Editas Medicine Inc (None–None)
Year-by-year capital reinvestment analysis for Editas Medicine Inc. See EDIT free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow